Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company
IRVINE, Calif., May 23, 2014 /PRNewswire/ -- Central Admixture Pharmacy Services, Inc. (CAPS®) announced today that its Vice President of Marketing and Professional Services, Michael Koch, R.Ph. MBA, was a guest speaker at this year's Louisiana Society of Health-System Pharmacists meeting in New Orleans. Mr. Koch presented an ACPE- accredited lecture entitled, "Ensuring Pharmacy Compliance and Patient Safety Under the Drug Quality and Security Act." Mr. Koch is considered an expert in this field and described the practice implications of pharmacy compounding sections of the Federal Food, Drug and Cosmetic Act (FFDCA), as well as outlining the federal requirements for "Traditional Pharmacy Compounders" (section 503A) and "Outsourcing Facilities" (section 503B). CAPS is proud to have such an expert as part of our team.
CAPS offers a unique dual approach to compounded sterile preparations, which includes both 503A and 503B facilities for all your compounding needs. CAPS Lehigh Valley is registered with the FDA as a 503B facility for your Anticipatory needs. CAPS also has 24 regional 503A facilities for your patient- specific customized compounding needs and offers unparalleled service, including same day delivery. CAPS is the market leader in Parenteral Nutrition (PN) and in addition to customized PN, offers hydration, antibiotics and other services for pediatrics and adults across the country. Consider CAPS for all your compounding needs. To learn more, visit CAPSpharmacy.com.
©2012 PR Newswire. All Rights Reserved.